Defilade Capital Management L.P. Purchases New Shares in Integer Holdings Corporation $ITGR

Defilade Capital Management L.P. purchased a new stake in shares of Integer Holdings Corporation (NYSE:ITGR) during the first quarter, HoldingsChannel reports. The fund purchased 213,027 shares of the medical equipment provider’s stock, valued at approximately $18,746,000. Integer accounts for approximately 2.6% of Defilade Capital Management L.P.’s portfolio, making the stock its 19th largest holding.

Several other institutional investors have also bought and sold shares of ITGR. Salomon & Ludwin LLC grew its stake in shares of Integer by 46.8% in the 4th quarter. Salomon & Ludwin LLC now owns 370 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 118 shares in the last quarter. EverSource Wealth Advisors LLC raised its position in shares of Integer by 48.1% during the 1st quarter. EverSource Wealth Advisors LLC now owns 360 shares of the medical equipment provider’s stock valued at $32,000 after buying an additional 117 shares in the last quarter. TD Private Client Wealth LLC lifted its holdings in shares of Integer by 1,037.5% in the 4th quarter. TD Private Client Wealth LLC now owns 455 shares of the medical equipment provider’s stock valued at $36,000 after acquiring an additional 415 shares during the last quarter. Parkside Financial Bank & Trust lifted its holdings in shares of Integer by 135.5% in the 4th quarter. Parkside Financial Bank & Trust now owns 464 shares of the medical equipment provider’s stock valued at $36,000 after acquiring an additional 267 shares during the last quarter. Finally, Arax Advisory Partners grew its position in Integer by 2,489.5% in the fourth quarter. Arax Advisory Partners now owns 492 shares of the medical equipment provider’s stock worth $39,000 after acquiring an additional 473 shares in the last quarter. Institutional investors own 99.29% of the company’s stock.

Integer Stock Performance

Shares of NYSE:ITGR opened at $121.07 on Monday. The company has a market capitalization of $4.11 billion, a price-to-earnings ratio of 30.19, a PEG ratio of 2.89 and a beta of 0.61. Integer Holdings Corporation has a 12 month low of $62.00 and a 12 month high of $123.50. The firm’s 50-day moving average is $93.88 and its 200 day moving average is $88.98. The company has a current ratio of 3.75, a quick ratio of 2.38 and a debt-to-equity ratio of 0.77.

Integer (NYSE:ITGR) last posted its quarterly earnings data on Thursday, April 30th. The medical equipment provider reported $1.20 earnings per share for the quarter, missing analysts’ consensus estimates of $1.21 by ($0.01). The firm had revenue of $439.58 million during the quarter, compared to analysts’ expectations of $426.48 million. Integer had a return on equity of 12.83% and a net margin of 7.64%.The business’s revenue for the quarter was up .5% compared to the same quarter last year. During the same period last year, the company earned $1.31 earnings per share. Research analysts predict that Integer Holdings Corporation will post 6.04 EPS for the current year.

Analyst Upgrades and Downgrades

ITGR has been the topic of several analyst reports. KeyCorp reissued an “overweight” rating and set a $104.00 price objective on shares of Integer in a research note on Tuesday, July 21st. Zacks Research raised Integer from a “strong sell” rating to a “hold” rating in a research note on Monday, July 20th. Citigroup lifted their target price on Integer from $92.00 to $96.00 and gave the stock a “neutral” rating in a report on Wednesday, July 8th. Weiss Ratings reissued a “hold (c)” rating on shares of Integer in a research report on Thursday, June 18th. Finally, Piper Sandler restated an “overweight” rating and set a $97.00 price target (up from $87.00) on shares of Integer in a report on Friday, May 1st. One equities research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and seven have given a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $97.00.

About Integer

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.